How have TRPXY shares performed in 2024?

Therapix Biosciences' stock was trading at $6.03 at the beginning of the year. Since then, TRPXY shares have increased by 0.0% and is now trading at $6.03. View the best growth stocks for 2024 here .

How do I buy shares of Therapix Biosciences?

Shares of TRPXY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:TRPXY

Therapix Biosciences (TRPXY) Stock Price, News & Analysis

→ Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad)

Free TRPXY Stock Alerts

$6.03

+0.03 (+0.50%)

(As of 02/9/2021)

Compare

Today's Range: $6.00
▼
$6.15
50-Day Range: $6.03
▼
$6.03
52-Week Range: $2.75
▼
$22.40

Volume: 53,500 shs
Average Volume: 12,316 shs
Market Capitalization: $6.25 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Therapix Biosciences alerts:

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

About Therapix Biosciences

Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110, which has completed Phase II a clinical trial for the treatment of Tourette syndrome and Obstructive Sleep Apnea; THX-160, which has completed two preliminary preclinical studies for the treatment of acute and chronic pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy. Therapix Biosciences Ltd. has a collaboration with The University of Calgary to evaluate the analgesic effect of Therapix's CB2R agonist proprietary drug candidate, THX-160. The company was formerly known as NasVax Ltd. and changed its name to Therapix Biosciences Ltd. in November 2013. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel.

TRPXY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TRPXY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive TRPXY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Therapix Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:TRPXY
CUSIP: N/A
CIK: N/A
Web: therapixbio.com
Phone: 972 3 616 7055
Fax: N/A
Employees: 8
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 1,037,000
Free Float: N/A
Market Cap: $6.25 million
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Oz Adler CPA (Age 34)
Chief Financial Officer
Comp: $220k

Key Competitors

View All Competitors

TRPXY Stock Analysis - Frequently Asked Questions

How have TRPXY shares performed in 2024?: Therapix Biosciences' stock was trading at $6.03 at the beginning of the year. Since then, TRPXY shares have increased by 0.0% and is now trading at $6.03.
View the best growth stocks for 2024 here.
How do I buy shares of Therapix Biosciences?: Shares of TRPXY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TRPXY) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial